Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Agfa Healthcare
Schiller

Carotid Artery MRI May Predict Probability of Heart Attack, Stroke

By Medimaging International staff writers
Posted on 17 Mar 2014
Image: Transverse (a) T2-weighted, (b) unenhanced T1-weighted, and (c) gadolinium-enhanced T1-weighted MR images in an 82-year-old man. The left ICA wall shows no plaque or significant wall thickening. The right ICA shows plaque with a lipid core (arrow). ICA = internal carotid artery, ECA = external carotid artery, IJ = internal jugular vein (Photo courtesy of the Radiological Society of North America).
Image: Transverse (a) T2-weighted, (b) unenhanced T1-weighted, and (c) gadolinium-enhanced T1-weighted MR images in an 82-year-old man. The left ICA wall shows no plaque or significant wall thickening. The right ICA shows plaque with a lipid core (arrow). ICA = internal carotid artery, ECA = external carotid artery, IJ = internal jugular vein (Photo courtesy of the Radiological Society of North America).
Image: Transverse gadolinium-enhanced T1-weighted MR images obtained superior to the carotid artery bifurcation in a 72-year-old man. L = ICA (internal carotid artery) lumen. (a) Low-signal-intensity calcium (arrow) and lipid core (arrowheads) can be seen. (b) Note contouring of the ICA. The outer adventitial wall (red), lipid core (blue), calcification (green), and vessel lumen (purple) are visible (Photo courtesy of the Radiological Society of North America).
Image: Transverse gadolinium-enhanced T1-weighted MR images obtained superior to the carotid artery bifurcation in a 72-year-old man. L = ICA (internal carotid artery) lumen. (a) Low-signal-intensity calcium (arrow) and lipid core (arrowheads) can be seen. (b) Note contouring of the ICA. The outer adventitial wall (red), lipid core (blue), calcification (green), and vessel lumen (purple) are visible (Photo courtesy of the Radiological Society of North America).
Noninvasive magnetic resonance imaging (MRI) of carotid artery plaque can effectively forecast future cardiovascular events such as strokes and heart attacks in individuals without a history of cardiovascular disease, according to a new research.

Researchers have long known that some arterial plaque is more dangerous because of its vulnerability to rupture. MRI can distinguish facets of vulnerable plaque, such as a lipid core with a thin fibrous cap. This ability makes MRI a potentially valuable tool for identifying patients at risk for ensuing cardiovascular events.

To study the predictive benefits of MRI plaque imaging, researchers performed carotid artery ultrasound and MRI on 946 asymptomatic patients from the Multi-Ethnic Study of Atherosclerosis (MESA). The carotid arteries are very accessible for imaging, and their condition tends to reflect that of the coronary arteries that supply the heart with oxygenated blood.

The researchers, who published their findings online March 2014 in the journal Radiology, used ultrasound to evaluate carotid wall thickness and MRI to define carotid plaque composition and the remodeling index, a gauge of changes in vessel size. Imaging findings were compared with cardiovascular events, including heart attacks, stroke, and death, for an average of 5.5 years after examination.

“We studied asymptomatic individuals with a low risk of cardiovascular events at baseline and used noninvasive imaging to predict the risk of an event downstream,” said David A. Bluemke, MD, PhD, from the US National Institutes of Health Clinical Center (Bethesda, MD, USA). “This is the first population-based prospective study to determine if vulnerable plaque features by MRI add to the risk of a cardiovascular event beyond the traditional risk factors.”

Cardiovascular events occurred in 59 of the patients. Abnormal thickening of the carotid artery wall and the presence of a lipid core and calcium in the internal carotid artery on MRI were significant predictors of subsequent events. A lipid core was present in nearly half of the patients who had an event, compared with only 17.8% of those who did not have an event. “The primary factors that predicted future risk were measures of vessel wall thickness in combination with the presence or absence of a lipid core,” Dr. Bluemke said. “The presence of a lipid core was 50% more common in people who had subsequent events.”

Using MRI scanning improved the reclassification of baseline cardiovascular risk in the study group. When both the carotid remodeling index and lipid core were used for risk stratification, approximately 16% more patients with events and 7% without events were accurately reclassified compared with the use of traditional risk factors. “The results bolster the use of MRI as a surrogate marker of efficacy in therapeutic studies and point to a role in determining which patients might need more aggressive treatments,” Dr. Bluemke said. “As risk factor prediction gets better, we’ll be able to screen more intelligently and use more intensive treatments in those individuals who face a higher risk of cardiovascular events.”

Dr. Bluemke noted that sequences for plaque composition could be readily added to existing carotid MRI angiography protocols for clinical purposes. “Carotid MRI has significant advantages,” he stated. “The results are more reproducible than those of ultrasound.”

Dr. Bluemke emphasized that the availability and cost-effectiveness could restrict the use of MRI. However, ultrasound and computed tomography (CT) are practical options for screening, he noted, particularly with improvements in CT dose reduction.

Related Links:

US National Institutes of Health Clinical Center



Channels

Radiography

view channel
Image: The Siemens Healthcare Somatom Force CT system (Photo courtesy of Siemens Healthcare).

New CT Scanning Technology Is Faster, Uses Less Radiation, and Easier on the Kidneys

Patients who must undergo computed tomography (CT) scanning now have a new option for screening that is extremely fast, uses less radiation, and is safer for the kidneys. With US Food and Administration... Read more

Ultrasound

view channel
ge: Graphic of the way trans-Atlantic robot-assisted ultrasound is performed (Photo courtesy of Mount Sinai).

Telerobotic Approach Provides Virtual Ultrasound Evaluations for Physicians, Hospitals, and Communities

An American physician, while in Germany, used a computer to perform a robot-assisted transatlantic ultrasound exam on a person in Boston (MA, USA). In another study, a Swedish doctor, working in collaboration... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.